Paragon 28 Price to Sales Ratio 2020-2022 | FNA
Historical PS ratio values for Paragon 28 (FNA) over the last 10 years. The current P/S ratio for Paragon 28 as of February 03, 2023 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Paragon 28 P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2023-02-03 | 17.31 | 6.91 | |
| 2022-09-30 | 17.82 | $2.50 | 7.12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.346B | $0.147B |
| Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $230.517B | 25.29 |
| Edwards Lifesciences (EW) | United States | $50.772B | 33.11 |
| Alcon (ALC) | Switzerland | $37.369B | 32.17 |
| STERIS (STE) | Ireland | $21.864B | 27.21 |
| Teleflex (TFX) | United States | $12.124B | 19.67 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.123B | 11.16 |
| Penumbra (PEN) | United States | $9.913B | 2372.91 |
| Globus Medical (GMED) | United States | $7.950B | 40.42 |
| Glaukos (GKOS) | United States | $2.458B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.435B | 19.55 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.469B | 20.92 |
| Nevro (NVRO) | United States | $1.410B | 0.00 |
| Artivion (AORT) | United States | $0.566B | 0.00 |
